Similar articles for PMID: 8872055

Year	Number of Results
1992	1
1993	1
1994	10
1995	8
1996	8
1997	8
1998	11
1999	9
2000	10
2001	8
2002	1
2003	7
2004	1
2005	2
2012	1
2018	1
2022	2
2024	0

1

RET receptor tyrosine kinase gene mutations: molecular biological, physiological and clinical aspects.

Höppener JW, Lips CJ. Höppener JW, et al. Eur J Clin Invest. 1996 Aug;26(8):613-24. doi: 10.1111/j.1365-2362.1996.tb02144.x. Eur J Clin Invest. 1996. PMID: 8872055 Review. No abstract available.

2

RET and NTRK1 proto-oncogenes in human diseases.

Alberti L, Carniti C, Miranda C, Roccato E, Pierotti MA. Alberti L, et al. J Cell Physiol. 2003 May;195(2):168-86. doi: 10.1002/jcp.10252. J Cell Physiol. 2003. PMID: 12652644 Review.

3

[One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].

Fehmann HC, Göke B. Fehmann HC, et al. Z Gastroenterol. 1994 Jul;32(7):416-7. Z Gastroenterol. 1994. PMID: 7975780 German. No abstract available.

4

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, et al. Eng C, et al. Hum Mol Genet. 1994 Feb;3(2):237-41. doi: 10.1093/hmg/3.2.237. Hum Mol Genet. 1994. PMID: 7911697

5

[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].

Hofstra RM, van der Luijt RB, Lips CJ. Hofstra RM, et al. Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.

6

Genetics. One gene--four syndromes.

van Heyningen V. van Heyningen V. Nature. 1994 Jan 27;367(6461):319-20. doi: 10.1038/367319a0. Nature. 1994. PMID: 7906865 No abstract available.

7

Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.

DeLellis RA. DeLellis RA. Lab Invest. 1995 May;72(5):494-505. Lab Invest. 1995. PMID: 7745945 Review. No abstract available.

8

RET activation by germline MEN2A and MEN2B mutations.

Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L, et al. Borrello MG, et al. Oncogene. 1995 Dec 7;11(11):2419-27. Oncogene. 1995. PMID: 8570194

9

Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.

Carlomagno F, Melillo RM, Visconti R, Salvatore G, De Vita G, Lupoli G, Yu Y, Jing S, Vecchio G, Fusco A, Santoro M. Carlomagno F, et al. Endocrinology. 1998 Aug;139(8):3613-9. doi: 10.1210/endo.139.8.6124. Endocrinology. 1998. PMID: 9681515

10

Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.

Chappuis-Flament S, Pasini A, De Vita G, Ségouffin-Cariou C, Fusco A, Attié T, Lenoir GM, Santoro M, Billaud M. Chappuis-Flament S, et al. Oncogene. 1998 Dec 3;17(22):2851-61. doi: 10.1038/sj.onc.1202202. Oncogene. 1998. PMID: 9879991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year